
The Weekly Dose: Orforglipron Data, Sports Medicine, and Nusinersen Approval
This week's episode highlights new data on the newly approved oral GLP-1, orforglipron, the growing role of sports pharmacists, and FDA approval of a higher-dose regimen for spinal muscular atrophy.
In this episode of The Weekly Dose, hosts Danielle Valletti, assistant editor, and Kennedy Ferruggia, associate editor at Pharmacy Times, break down 4 major stories shaping pharmacy practice.
In the
The FDA has
The FDA has also






































































































